New Player In The Fight Against Resistant Fungal Infections In Phase 3 Trial

Rezofungin hopes to fight increasingly deadly hospital-acquired fungal infections.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news